European Directorate for the Quality of Medicines & Health Care ("EDQM") has issued a Certificate of Suitability for "Pantoprazole Sodium Sesquihydrate" for alternative process (Process - II) on 10th June 2024. This certification will enable IOL Chemicals and Pharmaceuticals Limited to export this product in European and other CEP accepting countries. Pantoprazole is used for heartburn, acid reflux and gastro-oesophageal reflux disease (GORD).
Shares of IOL Chemicals and Pharmaceuticals Limited was last trading in BSE at Rs. 378.75 as compared to the previous close of Rs. 381.05. The total number of shares traded during the day was 7063 in over 419 trades.
The stock hit an intraday high of Rs. 383.70 and intraday low of 378.05. The net turnover during the day was Rs. 2693938.00.